AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
Stock Information for AVEO Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.